Underway

CLEO Welcomes former Binance NFT Director Ryan Horn as Global Partnerships Lead

Source Node:
Time Stamp: April 16, 2024 6:00 AM - Modified On: April 16, 2024 - Published By:
Source Cluster:
Republished By Plato

  CLEO, a pioneering RWA (real world asset) technology platform leveraging Web3 to fuse real-world impact with digital asset utility and NFTs, proudly announces the addition of Ryan Horn to its team. As the former Binance NFT Director and a recognized leader in the realms of sports, entertainment, and brand crypto strategies, Ryan will serve as a key advisor and lead for global partnerships. Launched in 2023 with its Marketing for Good proposition (rewarding a prospect’s attention for a tokenized good in the world) and having already onboarded clients such

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

Source Node:
Time Stamp: January 29, 2024 6:55 AM - Modified On: January 29, 2024 - Published By:
Source Cluster:
Republished By Plato

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

The Tightrope of Regulation

Source Node:
Time Stamp: September 26, 2023 7:08 AM - Modified On: September 26, 2023 - Published By:
Source Cluster:
Republished By Plato

In a significant move at the recent G20 meeting in India, the International Monetary Fund (IMF) and the Financial Stability Board (FSB) released a joint paper outlining a framework for the global regulation of cryptocurrencies. While the proposals mostly tread familiar territory, what’s new is their conviction in crypto’s unstoppable growth and success. A flurry of optimism greeted the G20’s endorsement of the report because it advocates that countries don’t ban crypto. Hidden in its text, however, are some worrying signs. For example, on the first page, they state, “Widespread

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Insights from Davos. Web3 Consolidation Underway. Meta Alliance Launch. Web3 Reserve System.

Source Node:
Time Stamp: May 17, 2022 6:03 AM - Modified On: May 17, 2022 - Published By:
Source Cluster:
Republished By Plato

May 19, 2022 London UK. A consensus is emerging from multiple Davos insiders that the next wave of consolidation is about to hit the Crypto Markets as awareness of Web3 Applications continue to drive volume, growth and outlook. Despite the recent crypto market crash this month, M&A is again on the rise as the Volume of Deals increased 50X over the past year to $ 55B. “Since Web3 is the precursor to Metaverse market, our team has come up with a way for communities to combat some of the inherent